This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration. Need a new registration confirmation email? Click here
Enanta Pharmaceuticals, Inc., (Nasdaq:ENTA), a research and development-focused biotechnology company dedicated to creating small molecule drugs in the infectious disease field, will celebrate their recent initial public offering and recognize World Hepatitis Day (July 28) by visiting the NASDAQ MarketSite in Times Square on July 26.
Enanta, along with its partners, is working on therapies to treat hepatitis C, a liver disease affecting over 170 million people worldwide.
In honor of the occasion,
Jay R. Luly, Ph.D., President and CEO, will ring the Opening Bell.
NASDAQ MarketSite – 4 Times Square – 43
rd & Broadway – Broadcast Studio
Friday, July 26, 2013 – 9:15 a.m. to 9:30 a.m. ET
Contact: Carol Miceli (617) 607-0710
email@example.comNASDAQ MarketSite: Christine Barna (646) 441-5310
Christine.Barna@nasdaqomx.comFeed Information: Fiber Line (Encompass Waterfront): 4463
Gal 3C/06C 95.05 degrees West 18 mhz Lower DL 3811 Vertical FEC 3/4 SR 13.235 DR 18.295411 MOD 4:2:0 DVBS QPSK
Facebook and Twitter:
For multimedia features such as exclusive content, photo postings, status updates and video of bell ceremonies please visit our Facebook page at:
For news tweets, please visit our Twitter page at:
A live webcast of the NASDAQ Opening Bell will be available at:
To obtain a hi-resolution photograph of the Market Open, please go to
http://www.nasdaq.com/reference/marketsite_events.stm and click on the market open of your choice.
About Hepatitis C Virus (HCV)
Hepatitis C is a liver disease affecting over 170 million people worldwide. The virus is typically spread through direct contact with the blood of an infected person. Hepatitis C increases a person's risk of developing chronic liver disease, cirrhosis, liver cancer and death. There is an acute need for new HCV therapies that are safer and more effective for many variants of the virus.